CIK 0001703057 · Large accelerated filer
AbCellera Biologics Inc.
Sign in to watch- Ticker
- ABCL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- operating
- Phone
- (604) 559-9005
- Business address
- 150 W 4TH AVENUE, VANCOUVER, British Columbia, Canada, V5Y 1G6
- SC 13G/A Stake Amended Statement of Ownership
- 5 Insider Annual Insider Trading Report
- 5 Insider Annual Insider Trading Report
- 5 Insider Annual Insider Trading Report
- 5 Insider Annual Insider Trading Report
- 4 Option exercise Chief Financial Officer acquired 500,000 shares (option exercise)
- 4/A Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Option exercise Chief Operating Officer acquired 250,000 shares (option exercise)
- 424B3 Offering Prospectus
- 8-K Event Executive or director change
- 4 Open-market buy Director bought 86,938 shares at $14.02 ($1,218,871)
- 3 Insider Initial Statement of Ownership
- 424B3 Offering Prospectus
- 4/A Option exercise Chief Operating Officer acquired 83,333 shares (option exercise)
Page 11 of 17 · 325 filings